𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erythropoietin in thrombotic thrombocytopenic purpura and acute renal failure

✍ Scribed by Heidenreich, S. ;Rahn, K.-H. ;Zidek, W.


Publisher
Springer-Verlag
Year
1992
Tongue
English
Weight
529 KB
Volume
70
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

✦ Synopsis


In this study, erythropoietin serum levels were serially determined in eight patients with acute renal failure to get a lead on the etiology of anemia in acute renal failure and to address the relationship between erythropoietin synthesis and renal excretory performance. Erythropoietin serum levels rapidly decreased after onset of acute renal failure to values of 12.8 +/- 10.3 mU/ml compared to 16.8 +/- 9.4 mU/ml in healthy controls. After restoration of renal function, erythropoietin levels climbed slowly in six patients (15.2 +/- 5.3 mU/ml), and in relation to prolonged anemia in these patients, a relative deficiency of erythropoietin could be observed. In one patient with thrombotic thrombocytopenic purpura causing acute renal failure, the decline of erythropoietin secretion was not observed, and in a phase of the disease when plasma exchange therapy was interrupted, markedly increased erythropoietin levels, up to 182 mU/ml, were detected despite the renal failure. Focusing on erythropoietin secretion in thrombotic thrombocytopenic purpura, we followed hormone synthesis in two other patients with the same disease, one of whom had mild renal insufficiency and one had normal renal function. High erythropoietin levels of up to 205 mU/ml were found in these patients, similar to the peak levels found in the patient with complete renal failure. Plasmapheresis treatment reduced erythropoietin production in all three patients with thrombotic thrombocytopenic purpura. In summary, our study indicates that in most cases of acute renal failure, erythropoietin synthesis is compromised and may contribute to the development of anemia in renal failure and aggravate the persistence of anemia after restoration of renal function.(ABSTRACT TRUNCATED AT 250 WORDS)


πŸ“œ SIMILAR VOLUMES


Thrombotic thrombocytopenic purpura in p
✍ Nicki Panoskaltsis; Melanie P. Derman; Irene Perillo; James K. Brennan πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 427 KB

Thrombotic thrombocytopenic purpura pathologically consists of a thrombotic microangiopathy that classically spares lung tissues. We describe a case of TTP that presented as a pulmonary-renal syndrome. In reviewing the international literature, pulmonary involvement is not as rare as once was though

Acute thrombotic thrombocytopenic purpur
✍ Satheesh K. Kathula; Mallika Kamana; Tahir Naqvi; Sharda Gupta; Jae C. Chang πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 51 KB

## Abstract Release of unusually large von Willibrand factor (UL vWF) multimers and a deficiency of vWF metalloprotease may result in thrombotic thrombocytopenic purpura (TTP), a life threatening disease. Surgery has been associated with TTP, probably by releasing massive amounts of UL vWF. An asso

Fibrinogenolysis in thrombotic thrombocy
✍ Dr. Eizo Kakishita; Tetsuji Koyama; Mitsuhiro Higuchi; Osamu Kunitomi; Yoshio Ou πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 481 KB πŸ‘ 1 views

Coagulo-fibrinolytic factors were studied in five patients suffering from thrombotic thrombocytopenic purpura (TTP). The change in coagulation factors in the acute stage was mild compared with that found in disseminated intravascular coagulation (DIC). We observed a slight increase of fibrin-fibrino